在肿瘤微环境中提供抗原和共刺激的 mRNA-LNP 疫苗增强 CAR-T 细胞功能(CART-Vac)
mRNA-LNP vaccine providing antigen and co-stimulation in the tumor microenvironment enhances CAR T cell function (CART-Vac).
69.4分
★★★☆☆
站内排序·非疗效
ALL SOURCES
mRNA-LNP vaccine providing antigen and co-stimulation in the tumor microenvironment enhances CAR T cell function (CART-Vac).
Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
该研究为 EphA2 靶向 CAR-NK 细胞治疗在一系列儿童肉瘤中的临床评价提供了基础依据。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。